Search research articles
Contact Us
Filters
Showing results (101-110 of 194) with videos related to
Page
of 20
Sort By:
Der Urologe. Ausg. A
|
January 11, 2021
[Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]
Pia Paffenholz, Tim Nestler, Yasmine Maatoug, et al.
Therapeutic Advances in Urology
|
October 2, 2013
Controversies on individualized prostate cancer care: gaps in current practice
Steven Joniau, David Pfister, Alexandre de la Taille, et al.
European Urology Focus
|
June 25, 2020
Impact of the COVID-19 Pandemic on Urologists in Germany
Pia Paffenholz, Arne Peine, Nicolas Fischer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 4, 2012
Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra
Michael Pinkawa, Richard Holy, Marc D Piroth, et al.
BJU International
|
June 13, 2020
<sup>68</sup> Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer
David Pfister, Friederike Haidl, Tim Nestler, et al.
The Journal of Urology
|
December 12, 2023
Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection
Tim Nestler, Pia Paffenholz, David Pfister, et al.
European Urology Oncology
|
October 16, 2024
Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39
Constantin Rieger, Jörg Schlüchtermann, Michaela Lehmann, et al.
The Journal of Urology
|
February 8, 2024
Reply by Authors
Tim Nestler, Pia Paffenholz, David Pfister, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 27, 2009
Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy
Lawrence Koutcher, Nancy Lee, Michael Zelefsky, et al.
Nuklearmedizin. Nuclear Medicine
|
December 17, 2021
Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancer
Charlotte A Schneider, Philipp Täger, Jochen Hammes, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 194) with videos related to
Sort By:
Page
of 20
Der Urologe. Ausg. A
|
January 11, 2021
[Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]
Pia Paffenholz, Tim Nestler, Yasmine Maatoug, et al.
Therapeutic Advances in Urology
|
October 2, 2013
Controversies on individualized prostate cancer care: gaps in current practice
Steven Joniau, David Pfister, Alexandre de la Taille, et al.
European Urology Focus
|
June 25, 2020
Impact of the COVID-19 Pandemic on Urologists in Germany
Pia Paffenholz, Arne Peine, Nicolas Fischer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 4, 2012
Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra
Michael Pinkawa, Richard Holy, Marc D Piroth, et al.
BJU International
|
June 13, 2020
<sup>68</sup> Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer
David Pfister, Friederike Haidl, Tim Nestler, et al.
The Journal of Urology
|
December 12, 2023
Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection
Tim Nestler, Pia Paffenholz, David Pfister, et al.
European Urology Oncology
|
October 16, 2024
Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39
Constantin Rieger, Jörg Schlüchtermann, Michaela Lehmann, et al.
The Journal of Urology
|
February 8, 2024
Reply by Authors
Tim Nestler, Pia Paffenholz, David Pfister, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 27, 2009
Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy
Lawrence Koutcher, Nancy Lee, Michael Zelefsky, et al.
Nuklearmedizin. Nuclear Medicine
|
December 17, 2021
Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancer
Charlotte A Schneider, Philipp Täger, Jochen Hammes, et al.
Page
of 20